Literature DB >> 9067661

Levels of stem cell factor and interleukin-3 in serum in acute Plasmodium falciparum malaria.

H Burgmann1, S Looareesuwan, E C Wiesinger, W Winter, W Graninger.   

Abstract

The purpose of the present study was to measure serum concentrations of stem cell factor (SCF) and interleukin-3 (IL-3) in patients with acute Plasmodium falciparum malaria. Serum samples from 15 patients were taken on day of admission and days 7, 14, 21, and 28. Anemia developed in 80% of patients. A transient increase in IL-3 could be observed at the beginning of the disease. It remains controversial whether the measured concentrations of IL-3 and SCF correlate with the grade of anemia. The possibly suppressed IL-3 and SCF production may contribute to the prolonged anemia in P. falciparum malaria, as has been shown for erythropoietin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9067661      PMCID: PMC170507          DOI: 10.1128/cdli.4.2.226-228.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  8 in total

1.  Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages.

Authors:  I K McNiece; K E Langley; K M Zsebo
Journal:  Exp Hematol       Date:  1991-03       Impact factor: 3.084

2.  The importance of anaemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserythropoiesis and iron sequestration.

Authors:  R E Phillips; S Looareesuwan; D A Warrell; S H Lee; J Karbwang; M J Warrell; N J White; C Swasdichai; D J Weatherall
Journal:  Q J Med       Date:  1986-03

3.  In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor.

Authors:  C Sieff; E Guinan
Journal:  Stem Cells       Date:  1993-07       Impact factor: 6.277

4.  IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages.

Authors:  D E Hatzigeorgiou; S He; J Sobel; K H Grabstein; A Hafner; J L Ho
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

5.  Cause of anaemia in malaria.

Authors:  A W Woodruff; V E Ansdell; L E Pettitt
Journal:  Lancet       Date:  1979-05-19       Impact factor: 79.321

Review 6.  Anaemia of Plasmodium falciparum malaria.

Authors:  R E Phillips; G Pasvol
Journal:  Baillieres Clin Haematol       Date:  1992-04

7.  Serum concentrations of MIP-1 alpha and interleukin-8 in patients suffering from acute Plasmodium falciparum malaria.

Authors:  H Burgmann; U Hollenstein; C Wenisch; F Thalhammer; S Looareesuwan; W Graninger
Journal:  Clin Immunol Immunopathol       Date:  1995-07

8.  Serum levels of erythropoietin in acute Plasmodium falciparum malaria.

Authors:  H Burgmann; S Looareesuwan; S Kapiotis; C Viravan; S Vanijanonta; U Hollenstein; E Wiesinger; E Presterl; S Winkler; W Graninger
Journal:  Am J Trop Med Hyg       Date:  1996-03       Impact factor: 2.345

  8 in total
  4 in total

Review 1.  Cytokines in the pathogenesis of and protection against malaria.

Authors:  Iñigo Angulo; Manuel Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  A novel functional variant in the stem cell growth factor promoter protects against severe malarial anemia.

Authors:  Collins Ouma; Christopher C Keller; Gregory C Davenport; Tom Were; Stephen Konah; Michael F Otieno; James B Hittner; John M Vulule; Jeremy Martinson; John M Ong'echa; Robert E Ferrell; Douglas J Perkins
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

3.  Splenic Innate B1 B Cell Plasmablasts Produce Sustained Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-3 Cytokines during Murine Malaria Infections.

Authors:  Shu Shien Chin; Laurent Chorro; John Chan; Grégoire Lauvau
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

4.  Suppression of a novel hematopoietic mediator in children with severe malarial anemia.

Authors:  Christopher C Keller; Collins Ouma; Yamo Ouma; Gordon A Awandare; Gregory C Davenport; Tom Were; James B Hittner; John M Vulule; John M Ong'echa; Douglas J Perkins
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.